Drug Recall: CONGESTAID II Nasal Decongestant for Manufacturing Deviations
Ultra Seal Corporation is recalling CONGESTAID II Nasal Decongestant packets due to current Good Manufacturing Practice (cGMP) deviations. The voluntary nationwide recall affects 447,050 packets.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries mentioned in the source. The hazard is based on manufacturing process deviations without specific identified contamination, fitting the 'voluntary precautionary recalls' criterion.
Plain-English summary
Ultra Seal Corporation is recalling CONGESTAID II Nasal Decongestant (Phenylephrine HCl 5mg) 2-tablet packets due to current Good Manufacturing Practice (cGMP) deviations. The product was distributed by ZEE Medical Distributors, LLC and sold nationwide within the United States.
The recall was initiated due to cGMP deviations identified during manufacturing. The specific nature of these deviations is not detailed in the recall notice.
A total of 447,050 packets are affected. The recalled product includes Lot #AK9478 (expiration date 02/2022) and Lot #AK9799 (expiration date 09/2022). This recall was terminated on October 16, 2023.
Consumers who have purchased this product should stop using it. For further information or guidance on the recall, consumers may contact Ultra Seal Corporation or consult the FDA.
The recalled product
- Product
- CONGESTAID II Nasal Decongestant (Phenylephrine HCl 5mg) 2 tablet packets, Dist. by ZEE Medical Distributors, LLC Mason, OH 45040
- Manufacturer
- Ultra Seal Corporation
- Category
- Drug
- Hazard
- Affected units
- 447,050
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: AK9478
- Exp. Date 02/2022
- AK9799
- Exp. Date 09/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Ultra Seal Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Ultra Seal Corporation
See all →- ModeratePEPTIME Energy Caffeine Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExaprin Pain Reliever Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Terminator decongestant recalled for cGMP deviations
FDA (Drugs) · 2022-02-09
- ModerateLite Remfresh Melatonin Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateExtra Strength Un-Aspirin Acetaminophen Packets Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
Same hazard · manufacturing deviation
See all →- ModerateSynjardy XR Tablets Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2026-07-08
- ModerateDuloxetine delayed-release capsules recalled for N-nitroso impurity contamination
FDA (Drugs) · 2026-05-13
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateiVIZIA Dry Eye Lubricant Drops Recalled for Sterility Assurance
FDA (Drugs) · 2026-05-06
- ModerateFurosemide tablets recalled for presence of N-nitroso impurity
FDA (Drugs) · 2026-04-29